RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Cellectar Biosciences EBIT 2024

Cellectar Biosciences EBIT

-48.26 M USD

Cellectar Biosciences Dividend yield

Ticker

CLRB

ISIN

US15117F5008

WKN

A2NB71

In 2024, Cellectar Biosciences's EBIT was -48.26 M USD, a 23.87% increase from the -38.96 M USD EBIT recorded in the previous year.

The Cellectar Biosciences EBIT history

YEAREBIT (undefined USD)
2029e-
2028e180.01
2027e111.08
2026e28.43
2025e-12.32
2024e-48.26
2023-38.96
2022-28.81
2021-24.13
2020-15.3
2019-14.18
2018-11.65
2017-13.6
2016-9.45
2015-8.56
2014-9.67
2013-11.3
2012-8.75
2011-6.29
2010-4.14
2009-10.17
2008-16.59
2007-20.29

Cellectar Biosciences Aktienanalyse

What does Cellectar Biosciences do?

Cellectar Biosciences is a biotechnology company specializing in the development of innovative cancer therapies. It was founded in 2003 and is headquartered in Madison, Wisconsin, USA. The company's mission is to revolutionize cancer treatment by developing therapies with high efficacy. Cellectar Biosciences focuses on research and development in the areas of preclinical development, clinical trials, and product registration. It has expanded its business to include radiation therapy and imaging diagnostics. The company is divided into different divisions for effective work and specialization. It has partnerships with leading players in the biotechnology industry. Overall, Cellectar Biosciences has built an impressive portfolio of products and services to meet the needs of patients and healthcare providers and will continue to play a significant role in the biotechnology industry in the future. Cellectar Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Cellectar Biosciences's EBIT

Cellectar Biosciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Cellectar Biosciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Cellectar Biosciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Cellectar Biosciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Cellectar Biosciences Stock

How much did Cellectar Biosciences achieve in EBIT for the current year?

In the current year, Cellectar Biosciences has achieved an EBIT of -48.26 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Cellectar Biosciences.

How has the EBIT of Cellectar Biosciences developed in recent years?

The EBIT of Cellectar Biosciences has increased by 23.873% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Cellectar Biosciences?

The EBIT of Cellectar Biosciences is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Cellectar Biosciences pay?

Over the past 12 months, Cellectar Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cellectar Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cellectar Biosciences?

The current dividend yield of Cellectar Biosciences is .

When does Cellectar Biosciences pay dividends?

Cellectar Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cellectar Biosciences?

Cellectar Biosciences paid dividends every year for the past 0 years.

What is the dividend of Cellectar Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cellectar Biosciences located?

Cellectar Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cellectar Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cellectar Biosciences from 5/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Cellectar Biosciences pay the last dividend?

The last dividend was paid out on 5/17/2024.

What was the dividend of Cellectar Biosciences in the year 2023?

In the year 2023, Cellectar Biosciences distributed 0 USD as dividends.

In which currency does Cellectar Biosciences pay out the dividend?

The dividends of Cellectar Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cellectar Biosciences

Our stock analysis for Cellectar Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cellectar Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.